John Rex, Vice President and Head of Infection, Global Medicines Development, AstraZeneca to Present at the 11th Anti-Infectives Partnering and Deal-Making Conference on July 10-11, 2014, in Boston, MA
Boston, MA, USA., May 8, 2014 - (PressReleasePoint) - John Rex, Vice President and Head of Infection, Global Medicines Development at AstraZeneca will be a speaker and panelist at the 11th Anti-Infectives Partnering and Deal-Making Conference on July 10-11, 2014, in Boston, MA, by GTCBio.
GTCBio’s Anti-Infectives Partnering and Deal-Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.
The conference will discuss antibiotic valuation & reimbursements, pricing strategies, current trends and recent deals, investment and seed stage funding opportunities, government collaborations, non-dilutive funding, evolution of the regulatory framework and pathways for limited use. Participants include Yoav Golan, Tufts University School of Medicine; Michael N. Dudley, Rempex Pharmaceuticals/ The Medicines Company; Michael Eichberg, Achaogen; Barry Eisenstein, Cubist Pharmaceuticals; Mark Goldberger, Abbvie; Peter Hammann, Sanofi-Aventis Deutschland GmbH; Elizabeth Jungman, The Pew Charitable Trusts; Joseph Larsen, BARDA; Kevin Outterson, Boston University; Alex White, Roche; Barrett Thornhill, Antimicrobial Innovation Alliance; Benjamin Thorner, Merck Research Laboratories and many more!